BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Vipshop (VIPS) has carved a niche in discount e-commerce. This guide breaks down what to watch in the 2025 earnings s...
A blockbuster SpaceX IPO could reshape markets, but history shows the real winners are the infrastructure players beh...
A single tickers bundles seven YieldMax sleeves into YMAG, pulling in weekly distributions even as persistent NAV dec...
Cisco surged to new intraday highs on Tuesday as it rolled out AI driven cybersecurity and infrastructure tools. Aris...
Stellantis is betting big on a single brand to lift profits in North America. This strategic move centers on Ram and ...
Procter & Gamble anchors the dividend-growth crowd with a multi-decade streak and strong cash flow. The plain-as-day ...
A rising demand for care and resilient cash flow could make a top medical devices firm a lasting anchor for a long-te...
A leading technology analyst questions Intel's current stock value, arguing the market is pricing an AI cycle far int...
A mid-year departure of a physician from a Medicare Advantage network can trap beneficiaries until the January enroll...
A steady-income approach from JEPI tests traditional retirement cash flow models as market volatility shapes option p...
Palantir surged about 9% after announcing a Sovereign-AI partnership with NVIDIA, aimed at secure, air-gapped governm...